Modulation of amyloid fibril formation of plasma protein by saffron constituent “SAFRANAL (cas 116-26-7)”: Spectroscopic and imaging analyses
-
Add time:08/24/2019 Source:sciencedirect.com
Anti-amyloidogenic activity of safranal towards induced HSA amyloids has been observed using a variety of techniques including fluorescence, UV–visible, CD, DLS and microscopies. The HSA solution was pre-incubated at 65 °C for 120 h and, in between, the growth of amyloid fibrils, using ThT aggregation kinetics, was monitored at different time intervals. It was found that the amyloid fibril formation of HSA diminishes in presence of safranal and the inhibition was concentration dependent. The surface hydrophobicity of HSA amyloid fibrils also decreased in presence of safranal. The increased CR binding of HSA fibrils also decreased and high concentration of safranal causes the CR binding to resemble like that of native HSA. Both RLS and turbidity intensities were also in inverse relation to the safranal concentration. Safranal also has a good impact to protect the secondary structure of incubated HSA. From the electron microscopy it was seen that the fibrillar network of HSA amyloids gradually vanishes as the concentration of safranal increased. The largely decreased population of HSA aggregates in safranal containing solution as compared to the one without it also suggests the inhibition of formation of large fibrillar aggregates.
We also recommend Trading Suppliers and Manufacturers of SAFRANAL (cas 116-26-7). Pls Click Website Link as below: cas 116-26-7 suppliers
Prev:Experimental and computational investigation on the molecular interactions of SAFRANAL (cas 116-26-7) with bovine serum albumin: Binding and anti-amyloidogenic efficacy of ligand
Next:SAFRANAL (cas 116-26-7), a constituent of saffron, exerts gastro-protective effects against indomethacin-induced gastric ulcer) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- SAFRANAL (cas 116-26-7) and its analogs inhibit Escherichia coli ATP synthase and cell growth08/31/2019
- In-vitro evaluation of antioxidant, anti-elastase, anti-collagenase, anti-hyaluronidase activities of SAFRANAL (cas 116-26-7) and determination of its sun protection factor in skin photoaging08/30/2019
- Original articleThe effects of SAFRANAL (cas 116-26-7), a constitute of saffron, and metformin on spatial learning and memory impairments in type-1 diabetic rats: behavioral and hippocampal histopathological and biochemical evaluations08/29/2019
- Spectroscopic and computational evaluation on the binding of SAFRANAL (cas 116-26-7) with human serum albumin: Role of inner filter effect in fluorescence spectral correction08/28/2019
- Original articleSAFRANAL (cas 116-26-7) epoxide – A potential source for diverse therapeutic applications08/27/2019
- Research articleAnti-oxidative effects of SAFRANAL (cas 116-26-7) on immobilization-induced oxidative damage in rat brain08/26/2019
- SAFRANAL (cas 116-26-7), a constituent of saffron, exerts gastro-protective effects against indomethacin-induced gastric ulcer08/25/2019
- Experimental and computational investigation on the molecular interactions of SAFRANAL (cas 116-26-7) with bovine serum albumin: Binding and anti-amyloidogenic efficacy of ligand08/23/2019
- Binding of SAFRANAL (cas 116-26-7) to whey proteins in aqueous solution: Combination of headspace solid-phase microextraction/gas chromatography with multi spectroscopic techniques and docking studies08/22/2019


